Everolimus decreased IgA1 deposits in glomeruli of α1<sup>KI</sup>CD89<sup>Tg</sup> mice.
<p>8-week-old α1<sup>KI</sup>CD89<sup>Tg</sup> mice expressing human IgA1 and CD89 were used for testing everolimus as effective treatment with mTOR inhibitors (2 mg/kg/day; 10 mice) as compared to vehicle (10 mice). Glomeruli were stained with anti-human IgA1 antibodie...
Saved in:
| Main Author: | |
|---|---|
| Other Authors: | , , , , , , , , |
| Published: |
2025
|
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!